• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    1/5/23 1:01:24 PM ET
    $ABVC
    $AMTD
    $ANGO
    $APP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ABVC alert in real time by email

    Gainers

    • Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) gained 129% to $1.4200 after the company announced the FDA approved its IND submission, allowing the company to proceed with the clinical study of ABV-1519 for the treatment of non-small cell lung cancer.
    • AMTD Digital Inc. (NYSE:HKD) shares jumped 101% to $20.14.
    • Vyant Bio, Inc. (NASDAQ:VYNT) shares rose 59% to $1.2309 after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) surged 59% to $1.0350. Mobiquity completed financing to help fund the launch of new publisher focused platform for monetization and compliance.
    • NovoCure Limited (NASDAQ:NVCR) gained 51.8% to $107.04 after the company announced the LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone.
    • Zai Lab Limited (NASDAQ:ZLAB) shares gained 42.1% to $48.19 after the company announced the LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone.
    • Magic Empire Global Limited (NASDAQ:MEGL) jumped 42% to $1.8786.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) surged 34.6% to $0.2013.
    • Addentax Group Corp. (NASDAQ:ATXG) gained 32% to $1.5700.
    • Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) rose 31% to $15.24.
    • Golden Matrix Group, Inc. (NASDAQ:GMGI) gained 26.8% to $3.4238.
    • Ryvyl Inc. (NASDAQ:RVYL) jumped 23% to $0.6894.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) gained 22% to $0.9376.
    • Orchard Therapeutics plc (NASDAQ:ORTX) jumped 21.5% to $0.6260 after the company announced FDA clearance of the IND application for OTL-203 in MPS-IH.
    • Moxian (BVI) Inc (NASDAQ:MOXC) gained 18.8% to $0.63.
    • Argo Blockchain plc (NASDAQ:ARBK) rose 18.3% to $1.42. Roth Capital, on Wednesday, upgraded Argo Blockchain from Sell to Neutral and raised the price target from $0.25 to $1.
    • 9 Meters Biopharma, Inc. (NASDAQ:NMTR) gained 16.8% to $2.29.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) jumped 16.8% to $2.99.
    • Comstock Inc. (NYSE:LODE) gained 16.3% to $0.3965. Comstock announced consolidation of its properties in Comstock and silver city mining districts, increasing the company's total owned, published mineral resources.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) gained 15.6% to $5.64.
    • Oblong, Inc. (NASDAQ:OBLG) shares rose 15.4% to $2.5510 after gaining over 26% on Wednesday. Oblong announced a 1-for-15 reverse stock split.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) gained 14.2% to $0.4499.
    • AMTD IDEA Group (NYSE:AMTD) shares rose 14% to $1.8701. AMTD IDEA Group, during November, announced 1-for-2 ADS ratio change.
    • Dingdong (Cayman) Limited (NYSE:DDL) gained 13.6% to $6.08.
    • FibroGen, Inc. (NASDAQ:FGEN) rose 12.8% to $18.17. B of A Securities upgraded FibroGen from Neutral to Buy and raised the price target from $18 to $27.
    • ViewRay, Inc. (NASDAQ:VRAY) gained 12.8% to $4.8150. Chindex Medical acquired 10 ViewRay MRIdian systems for advanced cancer treatment.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 12.5% to $4.51 after gaining around 18% on Wednesday. Kiora Pharmaceuticals recently completed enrollment of clinical trial evaluating KIO-201 for persistent corneal epithelial defects.
    • Dada Nexus Limited (NASDAQ:DADA) gained 12.2% to $11.51.
    • AngioDynamics, Inc. (NASDAQ:ANGO) jumped 9% to $14.83 following better-than-expected quarterly results.
    • Lamb Weston Holdings, Inc. (NYSE:LW) gained 8.8% to $95.24 after the company reported better-than-expected Q2 results and raised FY23 guidance above estimates.


    Losers

    • Silvergate Capital Corporation (NYSE:SI) shares dipped 46.1% to $11.83 after the company announced select preliminary Q4 financial metrics and provided a business update. The company said it is reducing headcount by 40%.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 22.4% to $1.87. The company said it will miss its 10-Q filing deadline for the quarter ending Nov 26, 2022 and has also concluded that there is substantial doubt about its ability to continue as a going concern.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 21.7% to $8.57 after the company announced passage of a warrant proposal.
    • OpGen, Inc. (NASDAQ:OPGN) dropped 19.3% to $2.7914. OpGen announced a 1-for-20 reverse stock split.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) fell 17.7% to $0.1807.
    • Cryptyde, Inc. (NASDAQ:TYDE) fell 17.2% to $0.2899 after jumping 81% on Wednesday. Cryptyde announced 2023 corporate priorities for the next 12 months.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) dropped 17.1% to $0.7128.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 16.2% to $4.10 after jumping 25% on Wednesday. TC BioPharm, last month, posted 1H EPS of $1.13.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) declined 15.9% to $0.20.
    • Resources Connection, Inc. (NASDAQ:RGP) dropped 15.8% to $15.67 following quarterly results.
    • Lucira Health, Inc. (NASDAQ:LHDX) dropped 15% to $0.3595.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 14.2% to $1.87. InMed, last month, announced appointment of interim Chief Financial Officer and change of auditor.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 14% to $1.6250. Vivos Therapeutics shares jumped 154% on Wednesday after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
    • TuanChe Limited (NASDAQ:TC) fell 13.8% to $0.9306.
    • RPM International Inc. (NYSE:RPM) fell 12.9% to $85.37 after the company reported mixed Q2 results and said certain RPM businesses have experienced reduced customer demand.
    • AppLovin Corporation (NASDAQ:APP) dropped 12.3% to $9.56 after Benchmark initiated coverage on the stock with a Sell rating and a $7 price target.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 12.2% to $3.2050. Altis Motor Vehicles filed for offering of up to 20.46 million shares of class A common stock by selling stockholders.
    • Fortuna Silver Mines Inc. (NYSE:FSM) dipped 11.7% to $3.46.
    • Simulations Plus, Inc. (NASDAQ:SLP) dipped 11.6% to $33.25 following weak quarterly results.
    • The Simply Good Foods Company (NASDAQ:SMPL) fell 11.4% to $33.84 following Q1 results.
    • SentinelOne, Inc. (NYSE:S) dropped 11% to $13.34. Piper Sandler maintained SentinelOne with a Neutral and lowered the price target from $17 to $16.
    • Cue Health Inc. (NASDAQ:HLTH) fell 10.2% to $1.9298.
    • Geron Corporation (NASDAQ:GERN) shares fell 9.6% to $2.8850 after the company announced a proposed public offering.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dropped 7.1% to $34.83 after the company reported Q1 earnings results and issued guidance.
    • Frequency Electronics, Inc. (NASDAQ:FEIM) dropped 6.7% to $5.66.

    Also Check This Out Bitcoin Remains Stable; Huobi Token, Aptos Among Top Losers

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $AMTD
    $ANGO
    $APP

    CompanyDatePrice TargetRatingAnalyst
    The Simply Good Foods Company
    $SMPL
    3/16/2026$22.00Hold → Buy
    Jefferies
    RPM International Inc.
    $RPM
    3/4/2026$125.00Neutral → Outperform
    Robert W. Baird
    SentinelOne Inc.
    $S
    3/3/2026$13.00Equal Weight
    Wells Fargo
    Applovin Corporation
    $APP
    3/2/2026$340.00Sell → Neutral
    Arete
    Applovin Corporation
    $APP
    1/26/2026$700.00Hold → Buy
    Needham
    Applovin Corporation
    $APP
    1/14/2026$835.00Outperform
    Evercore ISI
    RPM International Inc.
    $RPM
    1/9/2026$115.00Neutral → Overweight
    Analyst
    SentinelOne Inc.
    $S
    1/5/2026$17.00Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $ABVC
    $AMTD
    $ANGO
    $APP
    SEC Filings

    View All

    InMed Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    4/3/26 4:19:20 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by InMed Pharmaceuticals Inc.

    424B5 - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    4/3/26 4:17:05 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vivos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)

    4/3/26 4:05:33 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    $ABVC
    $AMTD
    $ANGO
    $APP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for RYTELO issued to GERON CORP

    Submission status for GERON CORP's drug RYTELO (ORIG-1) with active ingredient IMETELSTAT has changed to 'Approval' on 06/06/2024. Application Category: NDA, Application Number: 217779, Application Classification: Type 1 - New Molecular Entity

    6/7/24 12:36:59 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AMTD
    $ANGO
    $APP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Edmondson Frazor Titus Iii

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:58:53 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Smiley Joshua L

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:59:18 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Amado Rafael

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:57:35 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AMTD
    $ANGO
    $APP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bed Bath & Beyond, Inc. to Expand Elfa International as a Global Growth Platform Under Existing Leadership

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or "BBBY") today announced plans to significantly expand Elfa as a core growth platform within its Home Services Pillar, alongside the signing of definitive agreements that include The Container Store and Closet Works. Founded in Stockholm, Sweden in 1948, Elfa is one of the world's leading modular storage and organization brands, known for its customizable closet systems, shelving solutions, and space optimization products. The brand has built a reputation for durability, flexibility, and design, and has historically been distributed in the United States primarily through The Container Store. As part of this next phase, Anders Ro

    4/2/26 1:09:00 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    RGP Appoints Ed Tracy, Jr. as Financial Services Industry Leader to Accelerate Growth Across Banking, Capital Markets, Wealth Management, and Insurance

    RGP (NASDAQ:RGP), a global professional services firm, today announced the appointment of Ed Tracy, Jr. as the Financial Services Industry leader. Tracy will drive client revenue generation, delivery excellence, and market expansion across RGP's financial services practice. He is based in New York and reports to Scott Rottmann, President of Consulting Services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402611821/en/Ed Tracy, Jr., Financial Services Industry Leader at RGP The appointment underscores RGP's continued investment in senior leadership to meet surging demand for integrated transformation services across financi

    4/2/26 9:00:00 AM ET
    $RGP
    Real Estate

    Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association

    PARIS and NEW YORK and LONDON, April 2, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., are pleased to announce that Dr. Calvin Choi, founder of AMTD IDEA, has been re-appointed as the Chief President of the Hong Kong Island Youth United Association (the "Association"). Recently, the Hong Kong Island Youth United Association formally approved its second-term honorary appointments and the new composition

    4/2/26 8:13:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    $ABVC
    $AMTD
    $ANGO
    $APP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Simply Good Foods upgraded by Jefferies with a new price target

    Jefferies upgraded Simply Good Foods from Hold to Buy and set a new price target of $22.00

    3/16/26 8:34:06 AM ET
    $SMPL
    Packaged Foods
    Consumer Staples

    RPM Inc upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded RPM Inc from Neutral to Outperform and set a new price target of $125.00

    3/4/26 8:30:31 AM ET
    $RPM
    Paints/Coatings
    Consumer Discretionary

    Wells Fargo initiated coverage on SentinelOne with a new price target

    Wells Fargo initiated coverage of SentinelOne with a rating of Equal Weight and set a new price target of $13.00

    3/3/26 8:30:47 AM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $AMTD
    $ANGO
    $APP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:31:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $ABVC
    $AMTD
    $ANGO
    $APP
    Leadership Updates

    Live Leadership Updates

    View All

    RGP Appoints Ed Tracy, Jr. as Financial Services Industry Leader to Accelerate Growth Across Banking, Capital Markets, Wealth Management, and Insurance

    RGP (NASDAQ:RGP), a global professional services firm, today announced the appointment of Ed Tracy, Jr. as the Financial Services Industry leader. Tracy will drive client revenue generation, delivery excellence, and market expansion across RGP's financial services practice. He is based in New York and reports to Scott Rottmann, President of Consulting Services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402611821/en/Ed Tracy, Jr., Financial Services Industry Leader at RGP The appointment underscores RGP's continued investment in senior leadership to meet surging demand for integrated transformation services across financi

    4/2/26 9:00:00 AM ET
    $RGP
    Real Estate

    RGP Advances Human-Centered Transformation, Appoints Terry Peters to Lead Brand Experience Practice

    RGP (NASDAQ:RGP), a global professional services firm, today announced Terry Peters as the leader of its Brand Experience (BX) Practice within its Consulting Segment. The appointment reinforces BX as a core differentiator in how the firm delivers transformation across finance, technology, and operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401844251/en/Terry Peters, Brand Experience (BX) Practice Leader at RGP As organizations accelerate AI adoption and enterprise transformation, RGP is doubling down on a fundamental belief: transformation succeeds when it starts with people. The firm's BX capability embeds human-c

    4/1/26 9:00:00 AM ET
    $RGP
    Real Estate

    RGP Appoints Prashant Lamba as CIO to Reimagine How Technology Enables Work, Talent, and Client Impact

      RGP (NASDAQ:RGP), a global professional services firm, today announced the appointment of Prashant Lamba as Senior Vice President and Chief Information Officer (CIO), a strategic addition that underscores the firm's commitment to reimagining how technology powers both customer and employee experience across the enterprise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326579745/en/Prashant Lamba, Senior Vice President and Chief Information Officer at RGP Lamba will lead RGP's technology vision and execution, advancing a unified digital ecosystem that supports the firm's integrated model across Consulting and On-Demand. H

    3/26/26 9:00:00 AM ET
    $RGP
    Real Estate

    $ABVC
    $AMTD
    $ANGO
    $APP
    Financials

    Live finance-specific insights

    View All

    AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

    Med Tech segment delivered its sixth consecutive quarter of double-digit growth Strong adjusted EBITDA Third consecutive quarter the Company raised full year FY 2026 guidance for net sales and Adjusted EBITDA AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the third quarter of fiscal year 2026, which ended February 28, 2026. Fiscal Year 2026 Third Quarter Highlights     Quarter Ended February 28, 2026   Pro Forma* YoY Growth Ne

    4/2/26 6:00:00 AM ET
    $ANGO
    Medical/Dental Instruments
    Health Care

    Lamb Weston Reports Third Quarter Fiscal 2026 Results; Increases Midpoint of Fiscal Year 2026 Net Sales and EBITDA Outlook and Reduces Expected 2026 Capital Expenditures

    Board of Directors Declares Quarterly Dividend of $0.38 per Share Lamb Weston Holdings, Inc. (NYSE:LW) announced today its results for the third quarter of fiscal 2026 and updated its full year financial targets for fiscal 2026. Summary of Third Quarter FY 2026 Results ($ in millions, except per share)     Q3 2026   Year-Over- Year Growth Rates   YTD 2026   Year-Over- Year Growth Rates Net sales $ 1,564.8   3 %   $ 4,842.2   1 % Income from operations $ 126.6   (49 )%   $ 422.3   (12

    4/1/26 8:30:00 AM ET
    $LW
    Packaged Foods
    Consumer Staples

    Novocure to Report First Quarter 2026 Financial Results

    Novocure (NASDAQ:NVCR) will report financial results for the first quarter 2026 on April 30, 2026, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m. EDT, April 30, to discuss the company's financial results for the three-month period that ended March 31, 2026. To access the conference call by phone, use the following conference call registration link and dial-in details will be provided. To access the webcast, use the following webcast registration link. The slides presented during the webcast and the corporate presentation can be accessed live from the Investor Relations page of Novocure's website, www.novocure.com/invest

    4/1/26 7:00:00 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $ABVC
    $AMTD
    $ANGO
    $APP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Golden Matrix Group Inc.

    SC 13D/A - Golden Matrix Group, Inc. (0001437925) (Subject)

    11/29/24 5:00:05 PM ET
    $GMGI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Mobiquity Technologies Inc.

    SC 13G/A - Mobiquity Technologies, Inc. (0001084267) (Subject)

    11/20/24 7:44:24 PM ET
    $MOBQ
    Advertising
    Consumer Discretionary